Literature DB >> 18679389

Efficient diagnosis of suspected functional bowel disorders.

Jenny Gunnarsson1, Magnus Simrén.   

Abstract

Functional bowel disorders (FBDs) are common disorders that are characterized by various combinations of abdominal pain and/or discomfort, bloating and changes in bowel habits. At present, diagnosing FBDs often incurs considerable health-care costs, partly because unnecessary investigations are performed. Patients are currently diagnosed as having an FBD on the basis of a combination of typical symptoms, normal physical examination and the absence of alarm features indicative of an organic gastrointestinal disease. Basic laboratory investigations, such as a complete blood count, measurement of the erythrocyte sedimentation rate and serological tests for celiac disease, are useful in the initial evaluation. No further investigations are needed for most patients who have typical symptoms and no alarm symptoms. The most important alarm symptoms include signs of gastrointestinal bleeding, symptom onset above 50 years of age, a family history of colorectal cancer, documented weight loss and nocturnal symptoms. The presence of alarm symptoms obviously does not exclude an FBD, but further investigation is needed before confirmation of the diagnosis. For patients with predominant and severe diarrhea, a more thorough diagnostic work-up should normally be considered, including colonoscopy with colonic biopsies and a test for bile-acid malabsorption.

Entities:  

Mesh:

Year:  2008        PMID: 18679389     DOI: 10.1038/ncpgasthep1203

Source DB:  PubMed          Journal:  Nat Clin Pract Gastroenterol Hepatol        ISSN: 1743-4378


  5 in total

1.  Efficacy of electroacupuncture in the treatment of functional constipation: A randomized controlled pilot trial.

Authors:  Qi-Ming Xue; Ning Li; Zhi-Shun Liu; Cheng-Wei Wang; Jian-Qin Lu
Journal:  Chin J Integr Med       Date:  2015-06-11       Impact factor: 1.978

Review 2.  Irritable bowel syndrome.

Authors:  Paul Enck; Qasim Aziz; Giovanni Barbara; Adam D Farmer; Shin Fukudo; Emeran A Mayer; Beate Niesler; Eamonn M M Quigley; Mirjana Rajilić-Stojanović; Michael Schemann; Juliane Schwille-Kiuntke; Magnus Simren; Stephan Zipfel; Robin C Spiller
Journal:  Nat Rev Dis Primers       Date:  2016-03-24       Impact factor: 52.329

3.  Organic colonic lesions in 3,332 patients with suspected irritable bowel syndrome and lacking warning signs, a retrospective case--control study.

Authors:  Hong-Xiang Gu; Ya-Li Zhang; Fa-Chao Zhi; Bo Jiang; Ying Huang
Journal:  Int J Colorectal Dis       Date:  2011-03-04       Impact factor: 2.571

Review 4.  Optimal management of constipation associated with irritable bowel syndrome.

Authors:  Manuele Furnari; Nicola de Bortoli; Irene Martinucci; Giorgia Bodini; Matteo Revelli; Elisa Marabotto; Alessandro Moscatelli; Lorenzo Del Nero; Edoardo Savarino; Edoardo G Giannini; Vincenzo Savarino
Journal:  Ther Clin Risk Manag       Date:  2015-05-30       Impact factor: 2.423

5.  Adherence to the pro-inflammatory diet in relation to prevalence of irritable bowel syndrome.

Authors:  Asma Salari-Moghaddam; Ammar Hassanzadeh Keshteli; Ahmad Esmaillzadeh; Peyman Adibi
Journal:  Nutr J       Date:  2019-11-11       Impact factor: 3.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.